Attend the Q1 Productions Life Science Regulatory Intelligence Conference

January 14, 2022 10:40 a.m. EST

Get instant alerts when news breaks on your stocks. Claim your one week free trial for StreetInsider Premium here.

Event Highlights:

  • Payer Perspectives on Diagnostic Evidence and Access
  • Evidence targets to increase coverage through laboratory benefit management
  • Defining diagnostic value versus cost for payer networks: generating and applying clinical evidence
  • The increased need for prior authorizations has an impact.
  • Impact of Health Policy Changes on Test Coverage and Reimbursement

Q1 Life Science Regulatory Intelligence Conference brings together experts from around the world in the fields of global intelligence, strategy, policy and law to share regulatory best practices.

Review how your peers inform internal stakeholders about regulatory changes and competitive intelligence, provide feedback on submissions, and comment…

Learn more>>

For more information, please visit

About InvestorWire

InvestorWire is the transfer service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wired broadcast products you’ll need to ensure your next press release grabs your target audience’s attention and stays with you. While our competitors come at you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all national versions. While other delivery services can provide a basic review of your release, InvestorWire helps you put your best foot forward with Improved press release.

With our competitors, the job is done the second your version crosses the wire. Not with InvestorWire. We include follow-up coverage of each release taking advantage of the ever-growing audiences of the 50+ brands who make up the InvestorBrandNetwork.

Get the most out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit

Please review the full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or republished:

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, California 90046
310.299.1717 Office
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Serious news for serious traders! Try Premium for free!

Comments are closed.